AstraZeneca and Bristol Myers Squibb reportedly in talks on a mega merger

AstraZeneca is said to be discussing a possible merger with Bristol Myers Squibb, according to a Financial Times report published on Sunday.

The combination would rank among the largest consolidations ever seen in the pharmaceutical sector, potentially reshaping the competitive landscape.

The report did not disclose any specific terms, timelines, or regulatory hurdles, and both companies have not issued formal statements.